Literature DB >> 22523459

Synthesis of Some New Isoxazoline Derivatives of Chalconised Indoline 2-one as a Potential Analgesic, Antibacterial and Anthelmimtic Agents.

P Mondal1, S Jana, A Balaji, R Ramakrishna, Lk Kanthal.   

Abstract

A series of novel 1[5"-(2"'-substituted phenyl)-4",5"'-dihydro isoxazole-3"-yl]-3-[(4 substituted phenyl)imino]1-3-dihydro-2H-indole-2-one were synthesized from different substituted chalconised indole-2,3-dione was prepared from the different chalconised Isatin. The structures of the compounds were elucidated by elemental and spectral (IR, (1)H NMR, and MS) analysis. The synthesized compounds were screened for their analgesic activity by the acetic acid induced Writhing method and in vitro antimicrobial activity against the Gram-positive bacteria-Staphylococcus aureus and the Gram-negative bacteria-Pseudomonas auroginosa, Pseudomonas mirabilis, and E. coli by the cup plate agar diffusion method. Compounds 6a(1), 6a(3), 6b(3), and 6b(2) were found to be active against bacteria. The compounds 6a(1), 6b(3), and 6a(3) show a significant analgesic activity. Synthesized compounds also screened for anthelmintic activity against Pheretima posthuma. Compounds 6a(1), 6b(1), and 6b(3) show significant anthelmintic activity.

Entities:  

Keywords:  Analgesic; anthelmintic; antibacterial; in vitro; isatin; isoxazoline

Year:  2012        PMID: 22523459      PMCID: PMC3326781          DOI: 10.4103/0975-1483.93574

Source DB:  PubMed          Journal:  J Young Pharm        ISSN: 0975-1483


INTRODUCTION

Isatin and isoxazoline are biologically active, synthetically useful, and important heterocycles having a wide role in medicinal chemistry. Isatin is an endogenous compounds[1] widely used as an antibacterial,[23] anti-inflammatory,[4] antifungal agent. Isoxazolines are also reported[5] to possess good antimicrobial, analgesic, anti-inflammatory activity. In view of the biological activities, some isatino isoxazoline derivatives and in continuation of our research work on synthesis of biologically active heterocyclic compounds, we investigated that the synthesis of some novel isoxazoline derivatives from chalconised isatin derivatives is synthesized and screened for their antibacterial activities against gm (+ve) and gm (–ve) bacteria, analgesic activity, and also anthelmintic activity. The structure of all compounds was established on the basis of spectral and elemental analysis. Almost all the isatino isoxazoline derivatives show very good antibacterial activities at 100 μm/ml and analgesic activity [Scheme 1].
Scheme 1

Synthesis of new isoxazoline derivatives

Synthesis of new isoxazoline derivatives

MATERIALS AND METHODS

Melting points were recorded in open capillary tubes and are uncorrected. The IR spectra are recorded on a SHIMADZU-FT-IR spectrophotometer. The 1H NMR spectra were recorded on a Bruker-400 MHz spectrometer. Mass spectra were recorded in Maldi MS which shows a m/z peak at 465. Purity of the compounds was checked by the TLC. The characterizations of the synthesized compounds were given in Table 1. For antibacterial activity, the microbial strains are taken from Utkal University, Vani Vihar, Bhubneswer. The title compounds were prepared using the general synthetic strategy for the preparation of isoxazolin derivatives from the chalcones described as follows.
Table 1

Characterization data of the synthesized compounds

Characterization data of the synthesized compounds

Preparation of 1[5”-(2”’-substituedphenyl)-4”,5”’-dihydro isoxazole-3”’-yl]-3-[(4 substituted phenyl)imino]1-3 dihydro-2H-indole-2-one (6a1–6a3), (6b1–6b3)

Compounds (isatinoid chalcones) of 0.1 m were dissolved in ethanol (Sol – 1). Hydroxyl amine of 0.1 m was dissolved in ethanol (Sol – 2) and 1 g of anhydrous sodium acetate was dissolved in 20 ml of glacial acetic acid (Sol – 3). Then Sol 1, 2, and 3 were taken in a RBF, and reflux the reaction mixture for about 6–8 h.[6] The content was kept overnight in room temperature. Collected and recrystallized from the ethanolchloroform mixture (1:1).

Antibacterial activity

In vitro antibacterial activity[7] was carried out against 24-h old cultures of four bacteria by the cup plate method. The compounds (6a1–6a3) (6b1–6b3) were tested against Pseudomonas mirabilis (ATCC-224), Pseudomonas auroginosa (ATCC-32), E. coli (ATCC-3), and Staphylococcus aureus (ATCC-44). For antibacterial studies, incubation was carried out at 37°C for 48 h. Ampicillin was used as a standard drug for antibacterial activity. The compounds were tested at a concentration of 100 μg/ml in dimethyl formamide against all organisms. The zone of inhibition was calculated in millimeters and compared with the standard. The results were reported in Table 2.
Table 2

Results of antibacterial activity

Results of antibacterial activity

Analgesic activity

The analgesic activity[8] was evaluated by the acetic acid induced Writhing test. Adult Swiss albino mice of either sex were used. Mice are made to writhe by a simple intraperitonial injection of 0.6% v/v aqueous acetic acid (0.1 ml/kg). Test substances were administered 30 min before the injection of acetic acid. Nimesulide was taken as a standard. The numbers of writhes (full extension of hind paws) were recorded. Results are given in Table 3.
Table 3

Analgesic activity of the compounds

Analgesic activity of the compounds

Anthelmintic activity

The anthelmintic activity was evaluated on adult Indian earthworm Pheretima posthuma due to its anatomical and physiological resemblance with the intestinal earthworm parasite of human beings.[9] The earthworms were collected from moist soil and washed to remove all fecal materials. The earthworms in 3–5 cm. in length and 0.1 to 0.1–2 cm in width were used for all experimental protocol. The newly synthesized compounds were tested for anthelmintic activity.[10] Pheretima posthuma of nearly equal size (6 cm ± 1) were selected randomly for the present study.[91112] The worms were acclimatized to the laboratory condition before experimentation. The earthworms were divided into four groups of six earthworms in each. Albendazole diluted to with normal saline solution to obtained 0.1% w/v, 0.2% w/v, 0.5% w/v, and 1% w/v served as standard and poured into petridishes. The synthesized compounds were prepared in a minimal quantity of DMSO and diluted to prepare four concentrations, i.e. 0.1% w/v, 0.2% w/v, 0.5% w/v, and 1% w/v for each compound. Normal saline serves as control. Six earthworms nearly equal size (6 cm ± 1) are taken for each concentration and placed in petridishes at room temperature.[10] The time taken for complete paralysis and death is recorded. The mean paralysis time and mean lethal time for each sample were calculated (each reading taken in triplicate). The time taken for worms to become motionless was noted as the paralysis time and to ascertain death, each worm was frequently applied with external stimuli which stimulates and induces movement in the earthworms, if alive.[11] All the results were shown in Table 4 and expressed as a mean±SEM of six worms in each group.
Table 4

Anthelmintic activity of the synthesized compounds

Anthelmintic activity of the synthesized compounds

RESULTS

The structures of newly synthesized compounds were elucidated by IR, 1H NMR, and mass spectroscopic analysis and reported as follows.

6a1: 1-(5-(4-nitroyphenyl)-4,5-dihydroisoxazol-3-yl)-3-(2-nitrophenylimino)indoline-2-one

IR (KBr, cm–1): 1328(ArNO2), 1630 (C=N), 1730 (C=O), 1044 (C–O), 841 (CH=CH of aroma) 1H NMR (DMSO-d6): 2.5–5.4 (dd H isoxazoline ring), 6.5–7.9 (8H, m, 2Ar–H); MS: m/z 457.10 (M+).

6a2: 1-(5-(4-hydroxyphenyl)-4,5 dihydroisoxazol-3-yl)-3-(2-nitrophenylimino) indoline-2-one

IR (KBr, cm–1): 1335 (ArNO2), 1634 (C=N), 1709 (C=O), 1014 (C–O), 3698 (Ar–OH). 1H NMR: (DMSO-d6): 4.8–5.1 (dd H isoxazoline ring), 11.0 (s, 1H, OH), 6.8–7.9 (8H, m, 2Ar–H); MS: m/z 428.11 (M+).

6a3: 1-(5-(4-methoxyphenyl)-4,5 dihydroisoxazol-3-yl)-3-(2-nitrophenylimino)indoline-2-one IR (KBr, cm–1)

2935 (Ar–CH3), 1402 (ArNO2), 1638 (C=N), 1709 (C=O), 1034 (C–O), 1H NMR (DMSO-d6): 4.7–4.9 (dd H isoxazoline ring), 6.5–7.37 (8H, m, 2Ar–H), 2.70 (3H, s, –OCH3); MS: m/z 442.13 (M+).

6b1: 3-(2 chlorophenylimino)-1-(5-(4-nitrophenyl)-4,5-dihydroisoxazole-3-yl)indoline-2-one

IR (KBr, cm–1): 1334 (ArNO2), 1564 (C=N), 1013 (C–O), 896 (CH=CH of aroma), 648 (C–Cl) 1H NMR (DMSO-d6): 2.4, 5.4 (dd H isoxazoline ring), 6.3–7.9 (8H, m, 2Ar–H). MS: m/z 446.08 (M+).

6b2: 3-(2-chlorophenylimino)-1-(5-(4-hydroxyphenyl)-4,5-dihydroisoxazole-3-yl) indoline-2-one

IR (KBr, cm–1): 3482 (Ar–OH), 1631 (C=N), 999 (C–O), 841 (CH=CH of aroma), 698 (C–Cl). 1H NMR (DMSO-d6): 4.8–5.0 (dd H isoxazoline ring), 11.0 (s, 1H, OH), 6.8–7.9 (8H, m, 2Ar–H). MS: m/z 417.09 (M+).

6b3: 3-(2 chlorophenylimino)-1-(5-(4-methoxyphenyl)-4,5-dihydroisoxazole-3-yl) indoline-2-one

IR (KBr, cm–1): 3482 (Ar–CH3), 1639 (C=N), 1064 (C–O), 1703 (C=O), 696 (C–Cl); 1H NMR (DMSO-d6): 4.7–4.9 (dd H isoxazoline ring), 6.5–7.37 (8H, m, 2Ar–H), 2.72 (3H, s, –OCH3). MS: m/z 431.10 (M+). The characterization of synthesized compounds is given in Table 1, the results of the antibacterial activity were reported in Table 2, and also the results of the analgesic and anthelmintic activity were reported in Tables 3 and 4, respectively.

DISCUSSION

Analytical data of the compounds support the proposed structures. All six compounds have shown good antibacterial activity. Among them, compounds 6a2, 6b1, and 6b2 show very good activity only against gm (–ve) bacteria, but not against gm (+ve), these are weak. However, compounds 6a3, 6b3, and 6a1 show good activity against both gm (+ve) and gm (–ve) bacteria. All the compounds also show good analgesic effects, among them 6a1, 6a3, and 6b3 exhibit significant analgesic activity (P<0.001), % of inhibition of 49.81, 67.51, and 64.78, respectively, as compared with standard Nimesulide (79.56). All the compounds also show good anthelmintic activity against Pheretima posthuma. However, compounds 6a1, 6b1, and 6b3 shows significant activity both in the case of paralysis and death time when compared with the standard albendazole given in Table 4.

CONCLUSION

On a critical overview of synthesized compounds, it has been found that compounds with methoxy (–OCH3) substitution on a phenyl ring at the para position and the hydroxy (–OH) group at the para-position found potent and chloro (–Cl) substitution also makes the compound potent antibacterial, analgesic, and anthelmintic agents including nitro (–NO2) substitution which also makes the compound potent anthelmintic agent. In conclusion, a novel series of isoxazolin analogous possessing indole nucleus were synthesized for their potential analgesic and antibacterial and anthelmintic activity. The presence of considerable analgesic, antibacterial, and anthelmintic activity in the test compounds may be endorsed to the presence of isoxazolin, indole, and phenyl ring, all of which together might have contributed for the increase in analgesic and lipophilic character responsible for penetration of the compound inside the bacterial strain.
  2 in total

1.  Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide.

Authors:  S N Pandeya; D Sriram; G Nath; E DeClercq
Journal:  Eur J Pharm Sci       Date:  1999-10       Impact factor: 4.384

2.  Synthesis and evaluation of 1,3 di-substituted schiff, mannich bases and spiro isatin derivatives.

Authors:  P Mondal; M Banerjee; S Jana; A Bose
Journal:  J Young Pharm       Date:  2010-04
  2 in total
  2 in total

1.  Synthesis and characterization of N-Mannich based prodrugs of ciprofloxacin and norfloxacin: In vitro anthelmintic and cytotoxic evaluation.

Authors:  Mona Piplani; Harish Rajak; Prabodh Chander Sharma
Journal:  J Adv Res       Date:  2017-06-13       Impact factor: 10.479

Review 2.  Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery.

Authors:  Rameshwar S Cheke; Vaishali M Patil; Sandip D Firke; Jaya P Ambhore; Iqrar A Ansari; Harun M Patel; Sachin D Shinde; Visweswara Rao Pasupuleti; Md Imtaiyaz Hassan; Mohd Adnan; Adel Kadri; Mejdi Snoussi
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.